MiMedx Group, Inc. (MDXG)
3.655
+0.06
(+1.81%)
USD |
NASDAQ |
May 19, 16:00
3.655
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group EPS Diluted (Quarterly) : -0.0732 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Anika Therapeutics, Inc. | -0.3737 |
| Gilead Sciences, Inc. | 1.612 |
| MannKind Corp. | -0.0539 |
| Precigen, Inc. | -0.0224 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.86M |
| Revenue (Quarterly) | 58.99M |
| Total Expenses (Quarterly) | 69.85M |
| Enterprise Value | 392.54M |
| Gross Profit Margin (Quarterly) | 70.05% |
| Profit Margin (Quarterly) | -18.41% |
| Earnings Yield | 5.59% |
| Operating Earnings Yield | 7.25% |
| Normalized Earnings Yield | 5.590 |